Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7062-40-0

Post Buying Request

7062-40-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7062-40-0 Usage

Description

5-BROMO-2-METHOXYPHENYLACETONITRILE, also known as 2-(5-Bromo-2-methoxyphenyl)acetonitrile, is an organic compound that serves as a crucial intermediate in the synthesis of various chemical compounds and pharmaceuticals. It is characterized by its unique molecular structure, which includes a bromo and methoxy group attached to a phenyl ring, with an acetonitrile group as a side chain. This structure endows it with specific chemical properties that make it valuable in the field of organic synthesis.

Uses

Used in Pharmaceutical Industry:
5-BROMO-2-METHOXYPHENYLACETONITRILE is used as a synthetic intermediate for the production of various pharmaceutical compounds. Its unique molecular structure allows for the creation of a wide range of derivatives with potential therapeutic applications, making it a valuable asset in the development of new drugs.
Used in Chemical Synthesis:
In the field of organic chemistry, 5-BROMO-2-METHOXYPHENYLACETONITRILE is used as a key building block for the synthesis of various organic compounds. Its versatile structure enables chemists to perform a range of reactions, such as substitution, addition, and condensation, to create new molecules with diverse properties and applications.
Used in Research and Development:
5-BROMO-2-METHOXYPHENYLACETONITRILE is also utilized in research and development laboratories for the exploration of new chemical reactions and the development of innovative synthetic methods. Its unique structure and reactivity make it an ideal candidate for studying various aspects of organic chemistry, including reaction mechanisms, stereochemistry, and catalyst design.

Check Digit Verification of cas no

The CAS Registry Mumber 7062-40-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,6 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 7062-40:
(6*7)+(5*0)+(4*6)+(3*2)+(2*4)+(1*0)=80
80 % 10 = 0
So 7062-40-0 is a valid CAS Registry Number.
InChI:InChI=1/C21H22N4O2S/c1-4-8-28-20-24-18-17(19(27)25-20)15(12-6-5-7-22-11-12)16-13(23-18)9-21(2,3)10-14(16)26/h4-7,11,15H,1,8-10H2,2-3H3,(H2,23,24,25,27)

7062-40-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(5-bromo-2-methoxyphenyl)acetonitrile

1.2 Other means of identification

Product number -
Other names 5-Bromo-2-methoxybenzyl cyanide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7062-40-0 SDS

7062-40-0Relevant articles and documents

Rapid and Simple Access to α-(Hetero)arylacetonitriles from Gem-Difluoroalkenes

Hu, Dandan,Liu, Jiayue,Ren, Hongjun,Song, Jinyu,Zhang, Jun-Qi,Zhu, Guorong

supporting information, p. 786 - 790 (2022/01/28)

A scalable cyanation of gem-difluoroalkenes to (hetero)arylacetonitrile derivatives was developed. This strategy features mild reaction conditions, excellent yields, wide substrate scope, and broad functional group tolerance. Significantly, in this reacti

TRIAZOLONE COMPOUNDS AND USES THEREOF

-

Paragraph 00124; 00126; 00127, (2013/09/26)

The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections. The invention disclosed herein is also directed to a methods of preventing the onset of and/or recurrence of acute and chronic myeloid leukemia, as well as other cancers, comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7062-40-0